Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Franz Hefti
CEO | Chief Executive Officer | 76 | 01.03.18 |
Jeffrey Sevigny
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.03.18 |
Emily Minkow
PRN | Corporate Officer/Principal | 41 | 01.11.18 |
Yong Dai
PRN | Corporate Officer/Principal | 53 | 01.02.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 34 248 033 | 29 795 530 ( 87,00 %) | 0 | 87,00 % |
Unternehmenskontakt
Prevail Therapeutics, Inc.
430 East 29th Street Suite 1520
10016, New York
+
http://www.prevailtherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-1.65% | 104 Mrd. | |
+6.75% | 97.47 Mrd. | |
+5.71% | 22.25 Mrd. | |
-12.60% | 21.68 Mrd. | |
-9.70% | 18.2 Mrd. | |
-39.98% | 17.02 Mrd. | |
-10.17% | 16.36 Mrd. | |
+6.12% | 14.39 Mrd. | |
+35.47% | 12.37 Mrd. |